U.S. Dermal Fillers Market Revenue & Forecast Analysis, 2026-2035

According to the American Society of Plastic Surgeons (ASPS), more than 5.3 million hyaluronic acid dermal filler procedures were performed in the United States in 2024, reflecting continued demand for minimally invasive aesthetic treatments. The growing preference for non-surgical facial rejuvenation, increasing demand for wrinkle reduction and facial volume restoration, rising awareness of aesthetic treatments, and advancements in dermal filler formulations are driving the growth of the U.S. dermal fillers market.

The U.S. dermal fillers market has witnessed steady historical growth, supported by rising demand for minimally invasive aesthetic procedures, increasing consumer interest in facial rejuvenation, and growing preference for natural-looking results. Continued innovation in hyaluronic acid formulations has also expanded treatment options for facial wrinkles, volume restoration, and contour enhancement. For instance, in April 2025, Evolus launched its Evolysse Form and Evolysse Smooth hyaluronic acid dermal fillers in the U.S., expanding its aesthetic product portfolio and introducing its Cold-X technology to the market.

The market is expected to maintain growth during the forecast period, driven by increasing adoption of personalized aesthetic treatments, demand for lip enhancement and facial volume restoration, and continued expansion of FDA-approved filler options. For instance, in May 2026, Merz Aesthetics received FDA approval for Belotero Volume (+) for midface volume restoration, followed by approval for Belotero Intense (+) in July 2026 for lip augmentation, broadening the company's U.S. dermal filler portfolio.

U.S. Dermal Fillers Market Overview

Base Year Market Size (2025): USD 2.1 Billion

CAGR: 10.1%

Forecast Year Market Size (2035): USD 5.4 Billion

Major Players:

• D AbbVie Inc. (Allergan Aesthetics)

• Galderma Group AG

• Merz Aesthetics

• Revance Therapeutics, Inc.

• Prollenium Medical Technologies, Inc.

U.S. Dermal Fillers Market Trends

The U.S. dermal fillers market is evolving toward natural-looking enhancements, personalized treatments, and products that improve skin quality alongside facial volume. While hyaluronic acid (HA) fillers remain widely used, collagen-stimulating products are gaining attention as consumer preferences shift toward subtle, longer-term aesthetic outcomes.

· Calcium hydroxylapatite (CaHA) and poly-L-lactic acid (PLLA) products are gaining attention for stimulating collagen production and supporting gradual improvements in facial volume and skin structure.

· Practitioners are tailoring filler selection, injection techniques, and treatment plans to individual facial anatomy, aesthetic goals, and desired outcomes.

· Demand extends beyond wrinkle correction to lip augmentation, chin and jawline contouring, midface volume restoration, and treatment of age-related facial changes.

· Manufacturers are developing products with different gel properties, flexibility, and lifting capabilities to suit specific facial areas and natural facial movement.

Collectively, the market is moving toward more individualized aesthetic care, with natural-looking results, collagen-stimulating products, and targeted facial restoration shaping product innovation and treatment preferences.

U.S. Dental Fillers Market Analysis

By Product Type

Hyaluronic acid fillers provide immediate facial volume restoration and wrinkle correction, while their gel-based formulations support lip enhancement, cheek augmentation, and other non-surgical facial contouring procedures

Based on product type, the U.S. dermal fillers market is categorized into hyaluronic acid, calcium hydroxylapatite, polylactic acid (PLLA), and collagen and PMMA microspheres. Hyaluronic acid dominated the market with the largest share of 76.46% in 2025.

By Treatment Type

Aesthetic treatments provide facial rejuvenation, wrinkle reduction, lip enhancement, and volume restoration, meeting consumer demand for minimally invasive procedures and natural-looking improvements.

Based on treatment type, the U.S. dermal fillers market is categorized into aesthetic/cosmetic and reconstructive/therapeutic applications. Aesthetic/cosmetic treatments hold the dominant position in 2025.

By Application

Facial Lines treatments address moderate-to-severe facial wrinkles and folds, helping smooth areas such as nasolabial folds and perioral lines through minimally invasive injectable procedures.

Based on application, the U.S. dermal fillers market is categorized into wrinkle correction/facial lines, lip augmentation, cheek/mid-face contouring, chin & jawline contouring, and others. Wrinkle correction/facial lines hold the dominant position in 2025.

By Gender

Female consumers drive demand for dermal fillers through their greater adoption of aesthetic treatments for wrinkle correction, lip enhancement, facial contouring, and age-related volume restoration.

Based on gender, the U.S. dermal fillers market is categorized into female and male consumers. Female consumers hold the dominant position in the market.

By Age Ground

Individuals aged 31–50 years seek dermal filler treatments to address visible wrinkles, early facial volume loss, and age-related changes while maintaining natural-looking facial features.

Based on age group, the U.S. dermal fillers market is categorized into 18–30 years, 31–50 years, and above 50 years. The 31–50 years segment holds the dominant position in 2025.

By End-use

Aesthetic Clinics provide specialized settings for dermal filler procedures, including wrinkle correction, lip augmentation, and facial contouring, supported by trained aesthetic practitioners and personalized treatment plans.

Based on end-use, the U.S. dermal fillers market is categorized into medspas, aesthetic clinics, cosmetic surgery centers, and others. Aesthetic clinics hold the dominant position in 2025.